New Mountain Finance Corporation Schedules its Third Quarter 2023 Earnings Release and Conference Call
NEW YORK–(BUSINESS WIRE)–New Mountain Finance Corporation (Nasdaq: NMFC) (“New Mountain” or “the Company”) announced today…
NEW YORK–(BUSINESS WIRE)–New Mountain Finance Corporation (Nasdaq: NMFC) (“New Mountain” or “the Company”) announced today…
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
If approved, odronextamab would be the first and only bispecific antibody approved in both FL…
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
WESTPORT, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage…
WESTPORT, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage…
Akari’s priority pipeline programs remain on track to begin enrollment in the registrational nomacopan Phase…
Akari’s priority pipeline programs remain on track to begin enrollment in the registrational nomacopan Phase…
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage…
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) — VantAI, a leading company focused on the…
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) — VantAI, a leading company focused on the…
EDISON, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
EDISON, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
TEL AVIV, Israel, Sept. 29, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or…